Lundbeck’s CEO on Developing Breakthrough Medications

How do CEOs determine focus areas and allocate budget to R&D initiatives? Deborah Dunsire, CEO of Lundbeck — a phamaceutical company specializing in neurology and psychology — explains.

By Kaitlin Milliken · April 27, 2021 · 1 min read

Related Resources Our team interviewed 10 CEOs to see what they had to say about innovating at big companies. Readers can also find out what type of CEO runs their organizations. iRobot CEO Colin Angle shares how his company’s innovation strategy and vision have changed as the…

More like this

Is Your Company Sabotaging Projects by Using the Wrong Evaluation Criteria?

Deploying AI at $28B Sun Life Financial: Learnings So Far

Fidelity, GM, and Best Buy Heath: Stories from the Front Line of Deploying New Technology

COMMENTS